A large Canadian university hospital, where EGFR testing for all advanced non-squamous NSCLC had been implemented in 2006, reported a 342-day median time to the detection of EGFR mutation after reviewing its program from its initiation to 2019 [23]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.